MeSH term
Frequency | Condition_Probility | Adult | 8 | 0.0 |
Body Composition/*genetics | 2 | 15.0 |
European Continental Ancestry Group/genetics | 4 | 0.0 |
Female | 8 | 0.0 |
Gene Frequency | 4 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Humans | 16 | 0.0 |
Male | 11 | 0.0 |
Receptors, Adrenergic, alpha-2/*genetics | 7 | 53.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Genotype | 7 | 0.0 |
Deoxyribonuclease HpaII | 2 | 2.0 |
Middle Aged | 5 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Alleles | 4 | 0.0 |
Heterozygote | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Tomography, X-Ray Computed | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Variation (Genetics) | 3 | 0.0 |
Twins/genetics | 2 | 20.0 |
Adolescent | 4 | 0.0 |
Attention Deficit Disorder with Hyperactivity/*genetics | 2 | 4.0 |
Child | 2 | 0.0 |
Family Health | 2 | 0.0 |
Linkage Disequilibrium | 3 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Receptors, Adrenergic, alpha-2/genetics | 2 | 66.0 |
Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human, Pair 10/genetics | 2 | 2.0 |
Genetic Markers | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
DNA/genetics | 2 | 0.0 |
